This website, hosted by the University of Washington School of Medicine, Department of Obstetrics & Gynecology, contains training tools, workshop materials and resources for implementing outpatient miscarriage management services.
Liletta, a new progestin intrauterine device (IUD), was approved by the FDA in February 2015. It is the same size and shape as the Mirena and contains the same dose of levonorgestrel. Learn more about Liletta by reading this edition of the Contraceptive Pearls.
Due to the risk of fetal anomalies with these medications, contraceptive counseling is particularly important for women taking anticonvulsants. This Contraceptive Pearl covers contraception and contraindications for patients on anticonvulsants.
For patients with a history of sexual trauma, pelvic exams may trigger PTSD symptoms. The techniques outlined in this Contraceptive Pearl of trauma-informed care can lead to an easier exam.
Some women avoid hormonal contraception due to concern about side effects. Other women want to steer clear of all medications. Regardless of their reason, women who prefer to avoid hormones have a variety of contraceptive options available.
Study explores how increasing reproductive health training in family medicine residents effects their competency and likelihood of providing these services after medical school.
The intrauterine device (IUD) is an excellent postpartum contraceptive method. Right after childbirth, women are certain that they are not pregnant, they are highly motivated to use contraception and they appreciate avoiding extra visits to the pharmacy or clinician’s office. This Contraceptive Pearl covers postpartum IUD insertion.